DBV Technologies (DBVT) Non-Current Assets (2015 - 2026)

DBV Technologies (DBVT) reported Non-Current Assets of $19.7 million for Q1 2026, down 8.0% year-over-year from $21.4 million in Q1 2025, and down 5.29% quarter-over-quarter from $20.8 million in Q4 2025.

DBV Technologies (DBVT) Non-Current Assets (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 12 years of Non-Current Assets data on file, last reported at $19.7 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $19.7 million, down 8.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.7 million (down 8.0% YoY), and the FY2025 annual result was $20.8 million, down 2.21% from the prior year.
  • Non-Current Assets eased to $19.7 million in Q1 2026 per DBVT's latest filing, from $20.8 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $27.1 million in Q1 2022 and troughed at $19.7 million in Q1 2026.
  • A 5-year average of $22.9 million and a median of $22.4 million in 2022 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Assets slumped 63.11% in 2022, then rose 18.44% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $23.4 million in 2022, then gained by 2.67% to $24.1 million in 2023, then declined by 11.63% to $21.3 million in 2024, then decreased by 2.21% to $20.8 million in 2025, then slipped by 5.29% to $19.7 million in 2026.
  • Business Quant data shows DBVT's Non-Current Assets at $19.7 million in Q1 2026, $20.8 million in Q4 2025, and $21.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 19.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.70 Mn
Dec 31, 2025 20.80 Mn
Sep 30, 2025 21.61 Mn
Jun 30, 2025 22.19 Mn
Mar 31, 2025 21.41 Mn
Dec 31, 2024 21.27 Mn
Sep 30, 2024 24.30 Mn
Jun 30, 2024 24.23 Mn
Mar 31, 2024 26.33 Mn
Dec 31, 2023 24.07 Mn
Sep 30, 2023 20.51 Mn
Jun 30, 2023 21.98 Mn
Mar 31, 2023 22.69 Mn
Dec 31, 2022 23.44 Mn
Sep 30, 2022 22.42 Mn
Jun 30, 2022 25.03 Mn
Mar 31, 2022 27.14 Mn
Dec 31, 2021 32.34 Mn
Sep 30, 2021 60.79 Mn
Jun 30, 2021 61.99 Mn